https://www.selleckchem.com/products/art0380.html
The severity of gastrointestinal and psychological symptoms at baseline was similar between both groups. Globally, there was an improvement in all symptoms in both groups. The proportion of participants with severe baseline gastrointestinal symptoms or pathologic anxiety scores that showed improvement was significantly higher in Group A (74% vs 23%, p=0.005; 47% vs 8%, p=0.02; respectively). Symptoms were reassessed at 6 and 12 months after the intervention among those participants in Group A who attended ≥ 80% sessions, and sustained r